Will Gary and the gang ADMIT they were WRONG?

[Skulnik]

<blockquote class="twitter-tweet"><p lang="en" dir="ltr">In an important moment for science and data transparency, <a href="https://twitter.com/TheLancet?ref_src=twsrc%5Etfw">@thelancet</a> announces that its 96,000 observational study on hydroxychloroquine has been RETRACTED. <br><br>A sad story but an important one. <a href="https://t.co/qfPRsBDmP7">https://t.co/qfPRsBDmP7</a> <a href="https://t.co/GMDgP34tyb">pic.twitter.com/GMDgP34tyb</a></p>— Jeremy Faust MD MS (@jeremyfaust) <a href="https://twitter.com/jeremyfaust/status/1268615125323272192?ref_src=twsrc%5Etfw">June 4, 2020</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

 

[Skulnik]

Just looking for the apology, none seen, they were WRONG AGAIN.


Hate to say it, BUTtttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt

 

[Skulnik]

Authors Retract Hydroxychloroquine Study, Citing Concern Over Data
By JANE GREENHALGH ? 1 HOUR AGO
Share
Tweet
Email
Hydroxychloroquine is used to treat autoimmune diseases like lupus and is being studied for use in treating and preventing COVID-19.
Hydroxychloroquine is used to treat autoimmune diseases like lupus and is being studied for use in treating and preventing COVID-19.
GEORGE FREY / AFP VIA GETTY IMAGES
A large study of the drug hydroxychloroquine has been retracted by three of its authors.

The paper, published in the journal the Lancet last month, concluded that hydroxychloroquine, taken either alone or with an antibiotic, to treat patients with COVID-19 was of no benefit and actually increased a patient's risk of dying.


The publication of the study prompted the World Health Organization (WHO) to halt its own study of hydroxychloroquine. The WHO has now resumed the trial.

The Lancet paper analyzed data, purported to be from COVID-19 patients in more than 600 hospitals around the world. The data were collected by a private company called Surgisphere, whose founder, Sapan Desai, is a co-author on the study.

Concerns were raised about the accuracy of the data and the paper started attracting criticism within days of its publication. In an open letter to the Lancet more than a hundred scientists and clinicians asked the journal to provide details about the data and called for the study to be independently validated.

So the Lancet launched an independent review and asked Surgisphere to transfer their complete database for evaluation. Surgisphere agreed to the review, but the third party reviewers told the Lancet that they were not able to access all the data, because the company said this would violate client agreements and confidentiality requirements.

It was this failure to independently audit the data that prompted three of the study's authors to retract the paper, saying they "can no longer vouch for the veracity of the primary data sources."

The Lancet issued a statement saying it takes issues of scientific integrity "extremely seriously," and there are still many outstanding questions about Surgisphere and the data used in the study.

The company issued a statement on its website pledging transparency, and says it is working to address all questions about the data it provided.

Copyright 2020 NPR. To see more, visit https://www.npr.org.
TAGS:

 

[Skulnik]

Hydroxychloroquine Study jumped on by the media to discredit DJT pulled from the Lancet
The medical journal The Lancet on Thursday retracted a large study on the use of hydroxychloroquine to treat COVID-19 because of potential flaws in the research data. The study, published two weeks ago, found no benefit to the drug ? and suggested its use may even increase the risk of death.

Thursday's retraction doesn't mean that the drug is helpful ? or harmful ? with respect to the coronavirus. Rather, the study authors were unable to confirm that the data set was accurate.


Researchers from Brigham and Women's Hospital in Boston had worked with a health care analytics company, Surgisphere Corp., on the study.

"After publication of our Lancet article, several concerns were raised with respect to the veracity of the data and analyses conducted by Surgisphere Corporation," the study authors wrote in their retraction.

The study authors said they launched an independent review to confirm the findings, but said the company would not provide access to all of the data.

"Based on this development, we can no longer vouch for the veracity of the primary data sources," the authors wrote.

So they refused to hand over the sources of their data, why would they do that unless it was a fake study just to make Trump look bad. This needs investigating.

[link to www.nbcnews.com (secure)]

 

[Skulnik]

Crow must not be on the menu.

 

[Skulnik]

Very Strange to be against a drug because you hate Trump, what's it called?




TDS?

 

[Skulnik]

 

[yyz]

Its obvious the Republicans got to the people running this and threatened them.

Damned shame. You guys will stop at nothing.

 

[WhatsHisNuts]

Can you show me the part where it says they are finding that taking Hydroxychloroquine helps with COVID-19?

:0003

 

[Skulnik]

Can you show me the part where it says they are finding that taking Hydroxychloroquine helps with COVID-19?

:0003

Please show me the part where the 3 people that ran the study won't release the data?


Thank youuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu

 

[WhatsHisNuts]

Please show me the part where the 3 people that ran the study won't release the data?


Thank youuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuuu

All along I have said there is no reason to push a Malaria drug as a potential treatment if there is no evidence it works. THAT HAS NOT CHANGED.

Go pop a couple pills and don't forget your Clorox chaser!

 

[WhatsHisNuts]

Dear Asswipe, I think this article might be of interest to you.....

https://www.wsj.com/articles/fda-wi...r-hydroxychloroquine-for-covid-19-11592238129

 

[yyz]

Where is my apology?

:0corn

 

[WhatsHisNuts]

Skulnik: I would like an apology, too.